Gitterman Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Gitterman Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$314.42 - $351.91 $107,846 - $120,705	-343 Reduced 28.87%	845 $297,000
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $336,477 - $383,842	1,188 New	1,188 $374,000
Q3 2022 Oct 27, 2022	SELL	$273.83 - $305.53 $28,752 - $32,080	-105 Reduced 12.03%	768 $221,000
Q2 2022 Aug 03, 2022	SELL	$234.96 - $292.55 $80,826 - $100,637	-344 Reduced 28.27%	873 $249,000
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $269,468 - $317,600	1,217 New	1,217 $318,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Gitterman Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gitterman Wealth Management, LLC with notifications on news.